Maisons Alfort, France

Christophe Yue


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christophe Yue

Introduction

Christophe Yue is a notable inventor based in Maisons Alfort, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic agents. With a total of 3 patents to his name, his work has the potential to impact medical treatments significantly.

Latest Patents

Yue's latest patents include groundbreaking research on piperazinone derivatives and their uses. His work on substituted piperazinones focuses on their therapeutic applications. Additionally, he has developed novel compounds that act as inhibitors of the binding of fibrinogen to the Gp iib/iiia platelet receptors. These compounds can be utilized therapeutically as antithrombotic agents, showcasing his innovative approach to addressing critical health issues.

Career Highlights

Christophe Yue is associated with Laboratoire L. Lafon, where he continues to push the boundaries of pharmaceutical research. His dedication to innovation in drug development has established him as a key figure in his field. His work not only contributes to scientific knowledge but also aims to improve patient outcomes through effective therapies.

Collaborations

Yue collaborates with esteemed colleagues, including Marguerite Henry and Thierry Giboulot. These partnerships enhance the research environment and foster the exchange of ideas, leading to more robust scientific advancements.

Conclusion

Christophe Yue's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work has the potential to lead to significant improvements in therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…